Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice.
D000038:Abscess; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004357:Drug Synergism; D007275:Injections, Intravenous; D007668:Kidney / Q000382:microbiology; D007674:Kidney Diseases / Q000188:drug therapy*; D008248:Lysostaphin / Q000627:therapeutic use; D008297:Male; D008712:Methicillin / Q000008:administration & dosage*; D051379:Mice; D013203:Staphylococcal Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D008248:Lysostaphin; D008712:Methicillin